This finding suggest that endocrine action of GHRH antagonists based on inhibition of GH/IGF-I axis, antitumor effects of these analogs can be exerted directly through GHRH-Rs expressed by CAKI-1 RCC [11, 22, 55, 65]. Here, GHRH is linked to renal cell carcinoma.